A new model of systemic drug rescue based on permeability characteristics of the blood-brain barrier in intracerebral abscess-bearing rats

J. M. Nazzaro, L. C. Rosenbaum, M. A. Pagel, Edward Neuwelt

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The authors report the results of their investigation of a systemic drug rescue method using antibody to a therapeutic drug based on the differential permeability of the blood-brain barrier to low- and high-molecular-weight compounds. Rats bearing intracerebral abscesses initially received systemic [125I]-gentamicin (M(r) 462) followed 60 minutes later by specific gentamicin antiserum (immune group) or normal rabbit serum (nonimmune group). Animals receiving antigentamicin immunoglobulin G (IgG, M(r) 150,000) demonstrated 90% binding of serum gentamicin. Immunoprecipitation of serum samples with protein A-Sepharose demonstrated that the increased binding of gentamicin in immune animals was due to antigen binding with antigentamicin IgG. By contrast, the percent of gentamicin bound to antibody within the brain did not differ between immune and nonimmune groups, implying that high-molecular-weight IgG was excluded from the brain and brain lesion. Significant differences in gentamicin deliveries were noted in the abscess, brain around the abscess, brain distant from the abscess, and normal brain areas. In contrast, analysis of comparable brain areas demonstrated no significant differences in gentamicin delivery between immune and nonimmune animals, indicating that the systemic presence of gentamicin antibody did not alter central nervous system delivery of unbound drug. These findings suggest that possibility of a drug rescue method using antidrug IgG, based on the differential permeability of the blood-brain barrier to drug versus antibody. While the present work was developed in a brain abscess model, the drug rescue method may also be applicable in the management of intracerebral tumors.

Original languageEnglish (US)
Pages (from-to)467-474
Number of pages8
JournalJournal of Neurosurgery
Volume74
Issue number3
StatePublished - 1991

Fingerprint

Drug Repositioning
Gentamicins
Blood-Brain Barrier
Abscess
Permeability
Brain Abscess
Immunoglobulin G
Antibodies
Brain
Molecular Weight
Serum
Pharmaceutical Preparations
Immunoprecipitation
Immune Sera
Central Nervous System
Rabbits
Antigens

Keywords

  • Abscess
  • Blood-brain barrier
  • Drug rescue
  • Escherichia coli
  • Gentamicin

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

A new model of systemic drug rescue based on permeability characteristics of the blood-brain barrier in intracerebral abscess-bearing rats. / Nazzaro, J. M.; Rosenbaum, L. C.; Pagel, M. A.; Neuwelt, Edward.

In: Journal of Neurosurgery, Vol. 74, No. 3, 1991, p. 467-474.

Research output: Contribution to journalArticle

@article{3d6da722bdc44343a271941e701db81c,
title = "A new model of systemic drug rescue based on permeability characteristics of the blood-brain barrier in intracerebral abscess-bearing rats",
abstract = "The authors report the results of their investigation of a systemic drug rescue method using antibody to a therapeutic drug based on the differential permeability of the blood-brain barrier to low- and high-molecular-weight compounds. Rats bearing intracerebral abscesses initially received systemic [125I]-gentamicin (M(r) 462) followed 60 minutes later by specific gentamicin antiserum (immune group) or normal rabbit serum (nonimmune group). Animals receiving antigentamicin immunoglobulin G (IgG, M(r) 150,000) demonstrated 90{\%} binding of serum gentamicin. Immunoprecipitation of serum samples with protein A-Sepharose demonstrated that the increased binding of gentamicin in immune animals was due to antigen binding with antigentamicin IgG. By contrast, the percent of gentamicin bound to antibody within the brain did not differ between immune and nonimmune groups, implying that high-molecular-weight IgG was excluded from the brain and brain lesion. Significant differences in gentamicin deliveries were noted in the abscess, brain around the abscess, brain distant from the abscess, and normal brain areas. In contrast, analysis of comparable brain areas demonstrated no significant differences in gentamicin delivery between immune and nonimmune animals, indicating that the systemic presence of gentamicin antibody did not alter central nervous system delivery of unbound drug. These findings suggest that possibility of a drug rescue method using antidrug IgG, based on the differential permeability of the blood-brain barrier to drug versus antibody. While the present work was developed in a brain abscess model, the drug rescue method may also be applicable in the management of intracerebral tumors.",
keywords = "Abscess, Blood-brain barrier, Drug rescue, Escherichia coli, Gentamicin",
author = "Nazzaro, {J. M.} and Rosenbaum, {L. C.} and Pagel, {M. A.} and Edward Neuwelt",
year = "1991",
language = "English (US)",
volume = "74",
pages = "467--474",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - A new model of systemic drug rescue based on permeability characteristics of the blood-brain barrier in intracerebral abscess-bearing rats

AU - Nazzaro, J. M.

AU - Rosenbaum, L. C.

AU - Pagel, M. A.

AU - Neuwelt, Edward

PY - 1991

Y1 - 1991

N2 - The authors report the results of their investigation of a systemic drug rescue method using antibody to a therapeutic drug based on the differential permeability of the blood-brain barrier to low- and high-molecular-weight compounds. Rats bearing intracerebral abscesses initially received systemic [125I]-gentamicin (M(r) 462) followed 60 minutes later by specific gentamicin antiserum (immune group) or normal rabbit serum (nonimmune group). Animals receiving antigentamicin immunoglobulin G (IgG, M(r) 150,000) demonstrated 90% binding of serum gentamicin. Immunoprecipitation of serum samples with protein A-Sepharose demonstrated that the increased binding of gentamicin in immune animals was due to antigen binding with antigentamicin IgG. By contrast, the percent of gentamicin bound to antibody within the brain did not differ between immune and nonimmune groups, implying that high-molecular-weight IgG was excluded from the brain and brain lesion. Significant differences in gentamicin deliveries were noted in the abscess, brain around the abscess, brain distant from the abscess, and normal brain areas. In contrast, analysis of comparable brain areas demonstrated no significant differences in gentamicin delivery between immune and nonimmune animals, indicating that the systemic presence of gentamicin antibody did not alter central nervous system delivery of unbound drug. These findings suggest that possibility of a drug rescue method using antidrug IgG, based on the differential permeability of the blood-brain barrier to drug versus antibody. While the present work was developed in a brain abscess model, the drug rescue method may also be applicable in the management of intracerebral tumors.

AB - The authors report the results of their investigation of a systemic drug rescue method using antibody to a therapeutic drug based on the differential permeability of the blood-brain barrier to low- and high-molecular-weight compounds. Rats bearing intracerebral abscesses initially received systemic [125I]-gentamicin (M(r) 462) followed 60 minutes later by specific gentamicin antiserum (immune group) or normal rabbit serum (nonimmune group). Animals receiving antigentamicin immunoglobulin G (IgG, M(r) 150,000) demonstrated 90% binding of serum gentamicin. Immunoprecipitation of serum samples with protein A-Sepharose demonstrated that the increased binding of gentamicin in immune animals was due to antigen binding with antigentamicin IgG. By contrast, the percent of gentamicin bound to antibody within the brain did not differ between immune and nonimmune groups, implying that high-molecular-weight IgG was excluded from the brain and brain lesion. Significant differences in gentamicin deliveries were noted in the abscess, brain around the abscess, brain distant from the abscess, and normal brain areas. In contrast, analysis of comparable brain areas demonstrated no significant differences in gentamicin delivery between immune and nonimmune animals, indicating that the systemic presence of gentamicin antibody did not alter central nervous system delivery of unbound drug. These findings suggest that possibility of a drug rescue method using antidrug IgG, based on the differential permeability of the blood-brain barrier to drug versus antibody. While the present work was developed in a brain abscess model, the drug rescue method may also be applicable in the management of intracerebral tumors.

KW - Abscess

KW - Blood-brain barrier

KW - Drug rescue

KW - Escherichia coli

KW - Gentamicin

UR - http://www.scopus.com/inward/record.url?scp=0025971482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025971482&partnerID=8YFLogxK

M3 - Article

C2 - 1993912

AN - SCOPUS:0025971482

VL - 74

SP - 467

EP - 474

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 3

ER -